Coya Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Coya Therapeutics, Inc. on June 26, 2025. The report details the results of the Company's Annual Meeting of Stockholders held on the same date. Coya Therapeutics is an emerging growth company incorporated in Delaware, with its common stock trading on The Nasdaq Stock Market LLC under the symbol "COYA."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the completion of the Annual Meeting, resulting in the election of directors and the ratification of the independent auditor.
Guidance, Outlook, and Governance Results
The Annual Meeting addressed two key proposals:
- Election of Directors: Three Class III directors were elected to serve three-year terms. The voting results were as follows:
- Howard Berman, Ph.D.: 5,821,649 votes For; 505,761 votes Withheld; 4,096,866 Broker Non-Votes.
- Arun Swaminathan, Ph.D.: 6,324,520 votes For; 2,890 votes Withheld; 4,096,866 Broker Non-Votes.
- Ann Lee, Ph.D.: 5,779,312 votes For; 548,098 votes Withheld; 4,096,866 Broker Non-Votes.
- Ratification of Auditors: The appointment of Weaver and Tidwell, L.L.P. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was approved.
- Votes For: 10,355,085
- Votes Against: 68,851
- Abstain: 340
- Broker Non-Votes: 0
The filing contains no specific management commentary on future guidance, risks, or contingencies beyond the standard disclosure of the meeting results.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the Company's most recent 10-K or 10-Q for financial performance data, as this 8-K does not include it.
- Confirm the tenure and background of the newly elected Class III directors (Berman, Swaminathan, Lee).
- Check for any subsequent filings regarding the audit scope or findings by Weaver and Tidwell, L.L.P.